|
Market Closed -
Nasdaq
02:30:00 24/01/2026 am IST
|
5-day change
|
1st Jan Change
|
|
56.21 USD
|
-1.70%
|
 |
+2.97%
|
-5.42%
|
|
21/01 |
When America Starts to Feel Like a Risky Asset
|  | |
20/01 |
Canaccord Genuity Upgrades BioMarin Pharmaceutical to Buy From Hold, Adjusts Price Target to $98 From $84
|
MT
| |
20/01 |
Greenland, Tariffs, and the Quiet Revolt of the Bond Market
| | |
20/01 |
Analyst recommendations: Intel, Philip Morris, Duolingo, Netflix, SanDisk…
| | |
14/01 |
BioMarin Pharmaceuticals Aims for Sustained Growth in 2026, Wedbush Says
|
MT
| |
13/01 |
BioMarin Pharmaceutical Reports Preliminary 2025 Revenue, Details Asset Write-Down
|
MT
| |
13/01 |
Biomarin Pharmaceutical Inc estimates $3.2 billion in total revenues for FY - SEC filing
|
RE
| |
13/01 |
BioMarin Pharmaceutical Names Arpit Dave Chief Digital and Information Officer
|
MT
| |
13/01 |
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
|
PR
| |
13/01 |
BioMarin Pharmaceutical Inc. Appoints Arpit Davé as Executive Vice President and Chief Digital and Information Officer
|
CI
| |
13/01 |
BioMarin Pharmaceutical Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 11:15 AM
| | |
09/01 |
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
|
PR
| |
08/01 |
Veeva Systems, BioMarin Pharmaceutical Enter Long-Term Partnership
|
MT
| |
08/01 |
Veeva and Biomarin form long-term strategic partnership
|
RE
| |
08/01 |
Veeva and BioMarin Form Long-Term Strategic Partnership
|
PR
| |
22/12 |
Truist Securities Lifts BioMarin Pharmaceutical Price Target to $100 From $80, Maintains Buy Rating
|
MT
| |
22/12 |
BioMarin Pharmaceutical Inc. Announces its Decision to Discontinue Development of BMN349
|
CI
| |
20/12 |
Health Care Up Amid Deal Activity -- Health Care Roundup
|
DJ
| |
20/12 |
Sector Update: Health Care Stocks Rise Late Afternoon
|
MT
| |
20/12 |
Sector Update: Health Care Stocks Higher Friday Afternoon
|
MT
| |
19/12 |
Sector Update: Health Care
|
MT
| |
19/12 |
Top Midday Gainers
|
MT
| |
19/12 |
Top Midday Stories: Oracle, Others Form JV to Oversee TikTok in US; More Drugmakers to Announce US Drug Price Deals
|
MT
| |
19/12 |
BioMarin Pharmaceutical Inc. submitted a non-binding indication of interest to acquire Amicus Therapeutics, Inc. from The Vanguard Group, Inc., Wellington Management Group LLP, BlackRock, Inc., William Blair Investment Management, LLC, and others for $4.7 billion.
|
CI
| |
19/12 |
Amicus Therapeutics, Inc., BioMarin Pharmaceutical Inc. - M&A Call
| |
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
